Abstract
Majocchi’s granuloma (MG) is a rare deep skin dermatophyte infection that can occur either in immunocompetent or in immunocompromised individuals. Oral itraconazole or terbinafine is considered to be the first choice of treatment. We report an immunocompetent man with deep nodular form of MG, the form which is generally found in immunosuppressed individuals. Previous treatment with either oral itraconazole or terbinafine yielded no apparent improvement. After a series of examination, the man was diagnosed as having Trichophyton rubrum-induced MG mixed with bacterial infection as evidenced by growth of Klebsiella pneumoniae in tissue bacterial culture. The patient was treated with a combination of cefoselis and levofloxacin for bacterial clearance followed by voriconazole treatment. After approximately 4 months of voriconazole treatment, the lesions completely resolved. Alternative medicine (voriconazole) can be considered in case of refractory infections during MG treatment.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11046-015-9902-5/MediaObjects/11046_2015_9902_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11046-015-9902-5/MediaObjects/11046_2015_9902_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11046-015-9902-5/MediaObjects/11046_2015_9902_Fig3_HTML.jpg)
References
Gill M, Sachdeva B, Gill PS, Arora B, Deep A, Karan J. Majocchi’s granuloma of the face in an immunocompetent patient. J Dermatol. 2007;34:702–4.
Kim JE, Won CH, Chang S, Lee MW, Choi JH, Moon KC. Majocchi’s granuloma mimicking Kaposi sarcoma in a heart transplant patient. J Dermatol. 2011;38:927–9.
Radentz WH, Yanase DJ. Papular lesions in an immunocompromised patient. Trichophyton rubrum granulomas (Majocchi’s granuloma). Arch Dermatol. 1993;129(1189–90):92–3.
Smith KJ, Welsh M, Skelton H. Trichophyton rubrum showing deep dermal invasion directly from the epidermis in immunosuppressed patients. Br J Dermatol. 2001;145:344–8.
Sequeira M, Burdick AE, Elgart GW, Berman B. New-onset Majocchi’s granuloma in two kidney transplant recipients under tacrolimus treatment. J Am Acad Dermatol. 1998;38:486–8.
Kanaan IC, Santos TB, Kac BK, Souza AM, Cerqueira AM. Majocchi’s granuloma—case report. An Bras Dermatol. 2015;90:251–3.
Kurian A, Haber RM. Tinea corporis gladiatorum presenting as a Majocchi granuloma. ISRN Dermatol. 2011;2011:767589.
Pietrzak A, Tomasiewicz K, Kanitakis J, Paszkowski T, Dybiec E, Donica H, et al. Trichophyton mentagrophytes-associated Majocchi’s granuloma treated with cryotherapy. Folia Histochem Cytobiol. 2012;50:486–9.
Chang SE, Lee DK, Choi JH, Moon KC, Koh JK. Majocchi’s granuloma of the vulva caused by Trichophyton mentagrophytes. Mycoses. 2005;48:382–4.
Ratajczak-Stefanska V, Kiedrowicz M, Maleszka R, Rozewicka M, Mikulska D. Majocchi’s granuloma caused by Microsporum canis in an immunocompetent patient. Clin Exp Dermatol. 2010;35:445–7.
Bae BG, Kim HJ, Ryu DJ, Kwon YS, Lee KH. Majocchi granuloma caused by Microsporum canis as tinea incognito. Mycoses. 2011;54:361–2.
Gupta AK, Prussick R, Sibbald RG, Knowles SR. Terbinafine in the treatment of Majocchi’s granuloma. Int J Dermatol. 1995;34:489.
Margolis DJ, Weinberg JM, Tangoren IA, Cheney RT, Johnson BL Jr. Trichophytic granuloma of the vulva. Dermatology. 1998;197:69–70.
Coelho WS, Diniz LM, Sousa Filho JB, Castro CM. [Case for diagnosis. Granuloma trichophyticum (Majocchi’s granuloma)]. An Bras Dermatol. 2009;84:85–6.
Bressan AL, Silva RS, Fonseca JC, Alves Mde F. Majocchi’s granuloma. An Bras Dermatol. 2011;86:797–8.
Li FQ, Lv S, **a JX. Majocchi’s granuloma after topical corticosteroids therapy. Case Rep Dermatol Med. 2014;2014:507176.
Tateishi Y, Sato H, Akiyama M, Abe M, Kobayashi H, Umehara S, et al. Severe generalized deep dermatophytosis due to Trichophyton rubrum (trichophytic granuloma) in a patient with atopic dermatitis. Arch Dermatol. 2004;140:624–5.
Collins MA, Lloyd R. Photo quiz. Treatment-resistant plaque on the thigh. Majocchi granuloma. Am Fam Physician. 2011;83:753–4.
Hellier FF. Trichophytic granuloma simulating Bazin’s disease. Br Med J. 1962;2:644–5.
Chen HH, Chiu HC. Facial Majocchi’s granuloma caused by Trichophyton tonsurans in an immunocompetent patient. Acta Derm Venereol. 2003;83:65–6.
Molina-Leyva A, Perez-Parra S, Garcia-Garcia F. Case for diagnosis. An Bras Dermatol. 2014;89:839–40.
Cho HR, Lee MH, Haw CR. Majocchi’s granuloma of the scrotum. Mycoses. 2007;50:520–2.
Feng WW, Chen HC. Majocchi’s granuloma in a 3-year-old boy. Pediatr Infect Dis J. 2006;25:658–9.
Gupta AK, Groen K, Woestenborghs R, De Doncker P. Itraconazole pulse therapy is effective in the treatment of Majocchi’s granuloma: a clinical and pharmacokinetic evaluation and implications for possible effectiveness in tinea capitis. Clin Exp Dermatol. 1998;23:103–8.
Romero FA, Deziel PJ, Razonable RR. Majocchi’s granuloma in solid organ transplant recipients. Transpl Infect Dis. 2011;13:424–32.
Steiner UC, Trueb RM, Schad K, Kamarashev J, Koch S, French LE, et al. Trichophyton rubrum-induced Majocchi’s granuloma in a heart transplant recipient. A therapeutic challenge. J Dermatol Case Rep. 2012;6:70–2.
Stoppie P, Borghgraef P, Borgers M. Cutaneous distribution of orally administered itraconazole in guinea pigs, studied by autoradiography. J Eur Acad Dermatol Venereol. 1994;3:475–8.
Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347:408–15.
Ally R, Schurmann D, Kreisel W, Carosi G, Aguirrebengoa K, Dupont B, et al. A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. Clin Infect Dis. 2001;33:1447–54.
Scott LJ, Simpson D. Voriconazole: a review of its use in the management of invasive fungal infections. Drugs. 2007;67:269–98.
Carrillo-Munoz AJ, Giusiano G, Guarro J, Quindos G, Guardia C, del Valle O, et al. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis. Int J Antimicrob Agents. 2007;30:157–61.
Ghannoum M, Isham N, Sheehan D. Voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis clinical trial. J Clin Microbiol. 2006;44:2579–80.
Jeu L, Piacenti FJ, Lyakhovetskiy AG, Fung HB. Voriconazole. Clin Ther. 2003;25:1321–81.
Weiler S, Fiegl D, MacFarland R, Stienecke E, Bellmann-Weiler R, Dunzendorfer S, et al. Human tissue distribution of voriconazole. Antimicrob Agents Chemother. 2011;55:925–8.
Acknowledgments
This work was supported by the Jiangsu Province Postdoctoral Research Finding Schemes (1302032B).
Author information
Authors and Affiliations
Corresponding author
Additional information
H. B. Liu and F. Liu have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Liu, H.B., Liu, F., Kong, Q.T. et al. Successful Treatment of Refractory Majocchi’s Granuloma with Voriconazole and Review of Published Literature. Mycopathologia 180, 237–243 (2015). https://doi.org/10.1007/s11046-015-9902-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-015-9902-5